The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
Open accessAbstract
PURPOSE: To review the available evidence of chemoembolization for unresectable hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Computerized bibliographic searches with MEDLINE and CANCERLIT databases from 1980 through 2000 were supplemented with manual searches, with the keywords "hepatocellular carcinoma," "liver cell carcinoma," "randomized controlled trial [RCT]," and "chemoembolization." Studies were included if patients with unresectable HCC were enrolled and if they were RCTs in which chemoembolization was compared with nonactive treatment (five RCTs) or if different transarterial modalities of therapy (13 RCTs) were compared. Data were extracted from each RCT according to the intention-to-treat method. Five of the RCTs with a nonactive treatment arm were combined by using the random-effects model, whereas all 18 RCTs were pooled from meta-regression analysis. RESULTS: Chemoembolization significantly reduced the overall 2-year mortality rate (odds ratio, 0.54; 95% CI: 0.33, 0.89; P =.015) compared with nonactive treatment. Analysis of comparative RCTs helped to predict that overall mortality was significantly lower in patients treated with transarterial embolization (TAE) than in those treated with transarterial chemotherapy (odds ratio, 0.72; 95% CI: 0.53, 0.98; P =.039) and that there is no evidence that transarterial chemoembolization is more effective than TAE (odds ratio, 1.007; 95% CI: 0.79, 1.27; P =.95), which suggests that the addition of an anticancer drug did not improve the therapeutic benefit. CONCLUSION: In patients with unresectable HCC, chemoembolization significantly improved the overall 2-year survival compared with nonactive treatment, but the magnitude of the benefit is relatively small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Quantitative Synthesis in Systematic Reviews
Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00008 · Cited by 2,517
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
Bruix, J., Llovet, J. M., Castells, A., Montañá, X., Brú, C., Ayuso, M. D. C., Vilana, R., & Rodés, J. (1998) · Hepatology · doi:10.1002/hep.510270617 · Cited by 533
Pelletier, G., Roche, A., Ink, O., Anciaux, M. L., Derhy, S., Rougier, P., Lenoir, C., Attali, P., & Etienne, J.-P. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90110-d · Cited by 417
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
Yuen, M.-F., Cheng, C.-C., Lauder, I. J., Lam, S.-K., Ooi, C. G., & Lai, C.-L. (2000) · Hepatology · doi:10.1002/hep.510310211 · Cited by 411
Pelletier, G., Ducreux, M., Gay, F., Luboinski, M., Hagège, H., Thong, D., Van Steenbergen, W., Buffet, C., Rougier, P., Adler, M., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80187-6 · Cited by 396
Lin, D.-Y., Liaw, Y.-F., Lee, T.-Y., & Lai, C.-M. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90436-2 · Cited by 294
Raoul, J., Guyader, D., Bretagne, J., Heautot, J., Duvauferrier, R., Bourguet, P., Bekhechi, D., Deugnier, Y. M., & Gosselin, M. (1997) · Hepatology · doi:10.1002/hep.510260511 · Cited by 286
Wu, C.-C., Ho, Y.-Z., Ho, W. L., Wu, T.-C., Liu, T.-J., & P'Eng, F.-K. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800820141 · Cited by 218
Mathurin, Rixe, Carbonell, Bernard, Cluzel, Bellin, Khayat, Opolon, & Poynard (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00286.x · Cited by 164
Izumi, R., Shimizu, K., IYOBE, T., Ii, T., Yagi, M., Matsui, O., Nonomura, A., & Miyazaki, I. (1994) · Hepatology · doi:10.1002/hep.1840200205 · Cited by 131
Stuart, K. E., Stokes, K., Jenkins, R. L., Trey, C., & Clouse, M. E. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3202::aid-cncr2820721112>3.0.co;2-4 · Cited by 93
Nicolucci, A. (1989) · JAMA · doi:10.1001/jama.262.15.2101 · Cited by 83
Kajanti, M. J., Pyrhönen, S. O., Mäntylä, M., & Rissanen, P. M. (1992) · American Journal of Clinical Oncology · doi:10.1097/00000421-199202000-00008 · Cited by 43
Treatment of unresectable hepatocellular carcinoma : Results of a randomized controlled trial
Lai, E. C. S., Tong, T. R. S.-W., Ong, G. B., & Wong, J. W. (1986) · World Journal of Surgery · doi:10.1007/bf01655321 · Cited by 38
Meta-analysis: formulating, evaluating, combining, and reporting
Normand, S.-L. T. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Explaining heterogeneity in meta-analysis: a comparison of methods
Thompson, S. G., & Sharp, S. J. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991030)18:20
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria
Goldberg, S. N., Grassi, C. J., Cardella, J. F., Charboneau, J. W., Dodd, G. D., Dupuy, D. E., Gervais, D., Gillams, A. R., Kane, R. A., Lee, F. T., et al. (2005) · Radiology · doi:10.1148/radiol.2353042205 · Cited by 1,193
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Maluccio, M., & Covey, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21161 · Cited by 840
Metadata
- Authors
- Cammà, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., Andreone, P., Craxì, A., & Cottone, M.
- Venue
- Radiology
- Published
- 2002-07
- Volume
- 224
- Issue
- 1
- Pages
- 47-54
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2171673899
- Cited by
- 851
- References
- 24
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.